FSS enrols first patients in FlexStent studies

Flexible Stenting Solutions (FSS) has enrolled the first patients in two trials of its FlexStent, a femoropopliteal stent and delivery system.

The two trials are the Japan FlexStent clinical trial and the US FlexStent OPEN trial in Belgium.

The prospective, multicentre and randomised Japan FlexStent clinical trial will enrol 100 patients and compare the FlexStent with balloon angioplasty.

The company hopes that the system will improve patient care in the high growth peripheral vascular segment.

Recommended Reports

KOL Perspectives: Views on initial Phase III data for etrolizumab in IBD

Vulvovaginal Candidiasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

Open-Angle Glaucoma Clinical Trial Anaylsis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

Marfan Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

Kaposi Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

View All

Companies Intelligence

FSS

View All